|
1
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross K and Jones RJ: Immune checkpoint
inhibitors in renal cell carcinoma. Clin Sci (Lond). 131:2627–2642.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dabestani S, Thorstenson A, Lindblad P,
Harmenberg U, Ljungberg B and Lundstam S: Renal cell carcinoma
recurrences and metastases in primary non-metastatic patients: A
population-based study. World J Urol. 34:1081–1086. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Motzer RJ, Escudier B, McDermott DF,
George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G,
Plimack ER, et al CheckMate 025 Investigators, : Nivolumab versus
everolimus in advanced renal-cell carcinoma. N Engl J Med.
373:1803–1813. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lei C, Lv S, Wang H, Liu C, Zhai Q, Wang
S, Cai G, Lu D, Sun Z and Wei Q: Leukemia inhibitory factor
receptor suppresses the metastasis of clear cell renal cell
carcinoma through negative regulation of the yes-associated
protein. DNA Cell Biol. 37:659–669. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen ZF, Xiao YJ, Huang ZH, Chen T, Zhao
SC, Jiang YD, Wu P and Zheng SB: Quantitative and comparative
proteomics analysis in clear cell renal cell carcinoma and adjacent
noncancerous tissues by 2-D DIGE. Nan Fang Yi Ke Da Xue Xue Bao.
37:1517–1522. 2017.(In Chinese). PubMed/NCBI
|
|
7
|
Silacci P, Mazzolai L, Gauci C,
Stergiopulos N, Yin HL and Hayoz D: Gelsolin superfamily proteins:
Key regulators of cellular functions. Cell Mol Life Sci.
61:2614–2623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu FX, Johnston PA, Südhof TC and Yin HL:
gCap39, a calcium ion- and polyphosphoinositide-regulated actin
capping protein. Science. 250:1413–1415. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thompson CC, Ashcroft FJ, Patel S, Saraga
G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE,
Lemoine NR, et al: Pancreatic cancer cells overexpress gelsolin
family-capping proteins, which contribute to their cell motility.
Gut. 56:95–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renz M, Betz B, Niederacher D, Bender HG
and Langowski J: Invasive breast cancer cells exhibit increased
mobility of the actin-binding protein CapG. Int J Cancer.
122:1476–1482. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ichikawa H, Kanda T, Kosugi S, Kawachi Y,
Sasaki H, Wakai T and Kondo T: Laser microdissection and
two-dimensional difference gel electrophoresis reveal the role of a
novel macrophage-capping protein in lymph node metastasis in
gastric cancer. J Proteome Res. 12:3780–3791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Xiao K, Chen S, Huang Z, Ye Y and
Chen T: Circular RNA hsa_circ_001895 serves as a sponge of
microRNA-296-5p to promote clear cell renal cell carcinoma
progression by regulating SOX12. Cancer Sci. 111:713–726. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kitamura H, Takahashi A, Takei F, Hotta H,
Miyao N, Shindo T, Igarashi M, Tachiki H, Kunishima Y, Muranaka T,
et al Sapporo Medical University Urologic Oncology Consortium, :
Molecular-targeted therapy and surgery may prolong survival of
renal cell carcinoma patients with bone metastasis: a
multi-institutional retrospective study in Japan. Anticancer Res.
36:5531–5536. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Partheen K, Levan K, Osterberg L, Claesson
I, Fallenius G, Sundfeldt K and Horvath G: Four potential
biomarkers as prognostic factors in stage III serous ovarian
adenocarcinomas. Int J Cancer. 123:2130–2137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li T, Hong X, Zhao J, Teng Y, Zheng J,
Chen H, Chen H and Li H: Gelsolin-like actin-capping protein is
associated with patient prognosis, cellular apoptosis and
proliferation in prostate cancer. Biomarkers Med. 10:1251–1260.
2016. View Article : Google Scholar
|
|
17
|
Yun DP, Wang YQ, Meng DL, Ji YY, Chen JX,
Chen HY and Lu DR: Actin-capping protein CapG is associated with
prognosis, proliferation and metastasis in human glioma. Oncol Rep.
39:1011–1022. 2018.PubMed/NCBI
|
|
18
|
De Corte V, Van Impe K, Bruyneel E,
Boucherie C, Mareel M, Vandekerckhove J and Gettemans J: Increased
importin-beta-dependent nuclear import of the actin modulating
protein CapG promotes cell invasion. J Cell Sci. 117:5283–5292.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu PJ, Hsu AL, Wang DS, Yan HY, Yin HL and
Chen CS: Phosphoinositide 3-kinase in rat liver nuclei.
Biochemistry. 37:5738–5745. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steger DJ, Haswell ES, Miller AL, Wente SR
and O'Shea EK: Regulation of chromatin remodeling by inositol
polyphosphates. Science. 299:114–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pellieux C, Desgeorges A, Pigeon CH,
Chambaz C, Yin H, Hayoz D and Silacci P: Cap G, a gelsolin family
protein modulating protective effects of unidirectional shear
stress. J Biol Chem. 278:29136–29144. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang S, Chi Y, Qin Y, Wang Z, Xiu B, Su
Y, Guo R, Guo L, Sun H, Zeng C, et al: CAPG enhances breast cancer
metastasis by competing with PRMT5 to modulate STC-1 transcription.
Theranostics. 8:2549–2564. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HL, Seligson D, Liu X, Janzen N, Bui
MHT, Yu H, Shi T, Figlin RA, Horvath S and Belldegrun AS: Using
protein expressions to predict survival in clear cell renal
carcinoma. Clin Cancer Res. 10:5464–5471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Visapää H, Bui M, Huang Y, Seligson D,
Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, et
al: Correlation of Ki-67 and gelsolin expression to clinical
outcome in renal clear cell carcinoma. Urology. 61:845–850. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu X, Cai L, Meng Q and Jin X: Gelsolin
inhibits the proliferation and invasion of the 786-0 clear cell
renal cell carcinoma cell line in vitro. Mol Med Rep.
12:6887–6894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kankaya D, Kiremitci S, Tulunay O and
Baltaci S: Gelsolin, NF-κB, and p53 expression in clear cell renal
cell carcinoma: Impact on outcome. Pathol Res Pract. 211:505–512.
2015. View Article : Google Scholar : PubMed/NCBI
|
